102 related articles for article (PubMed ID: 17853273)
1. Differential diagnosis of coagulation abnormalities in borderline personality disorder.
Malevani J; Mobascher J; Cordes J; Mobascher A
World J Biol Psychiatry; 2008; 9(1):78-80. PubMed ID: 17853273
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
Schwerthöffer D; Bäuml J; Rentrop M
Fortschr Neurol Psychiatr; 2013 Aug; 81(8):437-43. PubMed ID: 23939557
[TBL] [Abstract][Full Text] [Related]
3. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
Faltus FJ
Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
[TBL] [Abstract][Full Text] [Related]
4. Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine.
Steinert T; Schmidt-Michel PO; Kaschka WP
Pharmacopsychiatry; 1996 May; 29(3):111-4. PubMed ID: 8738316
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
[TBL] [Abstract][Full Text] [Related]
6. [Borderline personality disorder].
Galinowski A
Encephale; 2005 Oct; 31 Pt 2():S73-5. PubMed ID: 16673717
[No Abstract] [Full Text] [Related]
7. Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room.
Damsa C; Adam E; De Gregorio F; Cailhol L; Lejeune J; Lazignac C; Allen MH
Gen Hosp Psychiatry; 2007; 29(1):51-3. PubMed ID: 17189746
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
Bellino S; Paradiso E; Bogetto F
Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
[TBL] [Abstract][Full Text] [Related]
9. [Comorbidity in patients with narcissistic personality disorder in comparison to patients with borderline personality disorder].
Ritter K; Roepke S; Merkl A; Heuser I; Fydrich T; Lammers CH
Psychother Psychosom Med Psychol; 2010 Jan; 60(1):14-24. PubMed ID: 19235677
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.
Kellner M
Pharmacopsychiatry; 2007 Jan; 40(1):41. PubMed ID: 17327963
[No Abstract] [Full Text] [Related]
11. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.
Soler J; Pascual JC; Campins J; Barrachina J; Puigdemont D; Alvarez E; Pérez V
Am J Psychiatry; 2005 Jun; 162(6):1221-4. PubMed ID: 15930077
[TBL] [Abstract][Full Text] [Related]
12. Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.
Grootens KP; Verkes RJ
Pharmacopsychiatry; 2005 Jan; 38(1):20-3. PubMed ID: 15706462
[TBL] [Abstract][Full Text] [Related]
13. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
Leitner P; Serfling R
Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
[TBL] [Abstract][Full Text] [Related]
14. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain.
Pascual JC; Martín-Blanco A; Soler J
CNS Drugs; 2021 Sep; 35(9):1023-1032. PubMed ID: 34370282
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity of bulimia nervosa and personality disorder.
Yates WR; Sieleni B; Reich J; Brass C
J Clin Psychiatry; 1989 Feb; 50(2):57-9. PubMed ID: 2914881
[TBL] [Abstract][Full Text] [Related]
16. Altered platelet alpha 2-adrenergic receptor binding sites in borderline personality disorder.
Southwick SM; Yehuda R; Giller EL; Perry BD
Am J Psychiatry; 1990 Aug; 147(8):1014-7. PubMed ID: 2165368
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
[TBL] [Abstract][Full Text] [Related]
18. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
Ingenhoven TJ; Duivenvoorden HJ
J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
[TBL] [Abstract][Full Text] [Related]
19. Impact of borderline personality disorder on bulimia nervosa.
Rowe SL; Jordan J; McIntosh VV; Carter FA; Bulik CM; Joyce PR
Aust N Z J Psychiatry; 2008 Dec; 42(12):1021-9. PubMed ID: 19016090
[TBL] [Abstract][Full Text] [Related]
20. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
